| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |